{
    "nctId": "NCT01916837",
    "briefTitle": "Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer",
    "officialTitle": "Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Invasive Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 180,
    "primaryOutcomeMeasure": "The success rate in obtaining the Genomic Grade Index in clinical practice",
    "eligibilityCriteria": "Inclusion Criteria:\n\nHistologically confirmed invasive breast cancer meeting the following criteria:\n\n* T1, T2, or operable T3 disease\n* Zero to three positive lymph nodes and no distant metastases\n* Operable disease - Must have undergone breast-conserving surgery or mastectomy with either a sentinel node procedure or full axillary clearance\n\nExclusion Criteria:\n\n* No other invasive cancer within the past 5 years except for adequately treated carcinoma in situ of the cervix or non melanoma skin cancer\n* No psychological, familial, sociological, or geographical condition that would preclude entering into a clinical study",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}